-
1
-
-
84856245990
-
Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20
-
Weiszhar Z, Czucz J, Revesz C, Rosivall L, Szebeni J, Rozsnyay Z. Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20. Eur J Pharm Sci 2011;45:492-8.
-
(2011)
Eur J Pharm Sci
, vol.45
, pp. 492-498
-
-
Weiszhar, Z.1
Czucz, J.2
Revesz, C.3
Rosivall, L.4
Szebeni, J.5
Rozsnyay, Z.6
-
2
-
-
80052174164
-
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
-
Szebeni J, Muggia F, Gabizon A, Barenholz Y. Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Adv Drug Deliv Rev 2011;63:1020-30.
-
(2011)
Adv Drug Deliv Rev
, vol.63
, pp. 1020-1030
-
-
Szebeni, J.1
Muggia, F.2
Gabizon, A.3
Barenholz, Y.4
-
3
-
-
80052154470
-
Material properties in complement activation
-
Moghimi SM, Andersen AJ, Ahmadvand D, Wibroe PP, Andresen TL, Hunter AC. Material properties in complement activation. Adv Drug Deliv Rev 2011;63:1000-7.
-
(2011)
Adv Drug Deliv Rev
, vol.63
, pp. 1000-1007
-
-
Moghimi, S.M.1
Andersen, A.J.2
Ahmadvand, D.3
Wibroe, P.P.4
Andresen, T.L.5
Hunter, A.C.6
-
4
-
-
84862687917
-
Complement system and the brain: Selected pathologies and avenues towards engineering of neurological nanomedicines
-
Lettiero B, Andersen AJ, Hunter AC, Moghimi SM. Complement system and the brain: selected pathologies and avenues towards engineering of neurological nanomedicines. J Control Release 2012;161:283-9.
-
(2012)
J Control Release
, vol.161
, pp. 283-289
-
-
Lettiero, B.1
Andersen, A.J.2
Hunter, A.C.3
Moghimi, S.M.4
-
5
-
-
84872309685
-
Complement activation associated with polysorbate 80 in beagle dogs
-
Qiu S, Liu Z, Hou L, Li Y, Wang J, Wang H, et al. Complement activation associated with polysorbate 80 in beagle dogs. Int Immunopharmacol 2013;15:144-9.
-
(2013)
Int Immunopharmacol
, vol.15
, pp. 144-149
-
-
Qiu, S.1
Liu, Z.2
Hou, L.3
Li, Y.4
Wang, J.5
Wang, H.6
-
8
-
-
54849408545
-
Poly(ethylene glycol)s generate complement activation products in human serumthrough increased alternative pathway turnover and a MASP-2-dependent process
-
Hamad I, Hunter AC, Szebeni J, Moghimi SM. Poly(ethylene glycol)s generate complement activation products in human serumthrough increased alternative pathway turnover and a MASP-2-dependent process. Mol Immunol 2008;46:225-32.
-
(2008)
Mol Immunol
, vol.46
, pp. 225-232
-
-
Hamad, I.1
Hunter, A.C.2
Szebeni, J.3
Moghimi, S.M.4
-
9
-
-
0023131069
-
C3-like activity in C3-deficient dog serum
-
Johnson JP. C3-like activity in C3-deficient dog serum. Complement 1987;4:53-60. (Pubitemid 17015091)
-
(1987)
Complement
, vol.4
, Issue.1
, pp. 53-60
-
-
Johnson, J.P.1
|